Browse
Subject
Showing results 1,161 to 1,200 of 2,610
- imatinib (2)
- IMATINIB MESYLATE (1)
- immune cell-mediated cytotoxicity (1)
- Immunity (1)
- immunocytokine (1)
- IMMUNODEFICIENCY SYNDROME (1)
- IMMUNODOMINANT PEPTIDE (1)
- immunoglobulins (1)
- IMMUNOHISTOCHEMISTRY (2)
- Immunohistochemistry (1)
- immunohistochemistry (3)
- IMMUNOPHENOTYPE (1)
- Immunotherapy (1)
- immunotherapy (1)
- IMPACT (9)
- IMPAIRED GLUCOSE-TOLERANCE (1)
- IMPLICIT (1)
- Implicit solvent (1)
- IMPROVE (1)
- IMPROVES (1)
- In Situ Hybridization, Fluorescence (1)
- IN-HOSPITAL MORTALITY (1)
- in-hospital outcome (1)
- IN-SITU (2)
- IN-SITU HYBRIDIZATION (5)
- IN-VITRO (8)
- IN-VIVO (11)
- INACTIVATION (1)
- INCIDENTAL FINDINGS (1)
- INDEPENDENT GROWTH (1)
- INDEPENDENT MARKER (1)
- INDEPENDENT PROGNOSTIC MARKER (1)
- INDEX (2)
- INDICATOR (1)
- INDUCED AMENORRHEA (1)
- INDUCED CYCLOOXYGENASE-2 EXPRESSION (1)
- Induced pluripotent stem cells (1)
- INDUCERS (1)
- INDUCIBLE FACTOR-1-ALPHA (1)
- INDUCTION (5)